T. Rowe Price Associates »

Jazz Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2013-03-31 $54M 967k 55.91
2012-12-31 $55M 1.0M 53.20
2012-09-30 $58M 1.0M 57.01
2012-06-30 $41M 917k 45.01
2012-03-31 $42M 870k 48.47

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Jazz Pharmaceuticals

Vanguard Group
LSV Asset Management
Jpmorgan Chase & Co
Wellington Management Company
Polaris Capital Management
Pacer Advisors
EcoR1 Capital
Franklin Resources
Dimensional Fund Advisors
Bnp Paribas Investment Partners
Samlyn Capital
Millennium Management
Bank of New York Mellon
Charles Schwab Investment Management
Avidity Partners Management

View all funds holding Jazz Pharmaceuticals